DAZAP1 and osteoarthritis: By targeting the DAZAP1 and MAPK pathways, upregulated miR-320a improved IL-1β-induced osteoarthritis by enhancing chondrocyte proliferation, reducing apoptosis, and decreasing inflammatory response [52].